1. Imbruvica is the first FDA-approved therapy for the treatment of chronic graft versus host disease, which occurs when immune cells from donated tissues — often stem cells from donated bone marrow — attack the new host’s body cells.
2. Easyret photocoagulator laser is used to perform ocular laser surgery.
3. Idhifa is used to treat adults with relapsed or refractory acute myeloid leukemia who carry a specific genetic mutation.
4. Abilify Maintena is a once-daily injectable antipsychotic drug for intramuscular use.
More articles on supply chain:
Senate passes FDA user fee reauthorization bill
6 must-reads for supply chain leaders this week
10 most-read supply chain stories in July
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
